CTOs on the Move

RenalGuard Solutions

www.renalguard.com

 
Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Andrew Halpert
Chief Technology Officer Profile

Funding

RenalGuard Solutions raised $14.5M on 03/16/2017

Similar Companies

Luminex Corporation

Luminex Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

ifa united I tech

ifa united I tech is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Getinge Group

Getinge AB is a Sweden-based company active within the healthcare industry. The Company is engaged in the provision of equipment and services within three business areas: Medical Systems, with equipment for surgery and intensive care, Infection Control,

Invendo Medical

Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology. Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed. In order to achieve its goal the company first focussed on an application in the diagnosis and treatment of colorectal cancers (CRC). CRC is the second leading cause of cancer death with an estimated annual worldwide death toll of 510,000 people. More than 1 million new cases are diagnosed every year. However 90-100% of colorectal cancers can be avoided if diagnosed early on

Scilabs Nutracueticals

Scilabs Nutracueticals is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.